| 000 | 01572 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514001123.0 | ||
| 264 | 0 | _c20010628 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1006/gyno.2001.6197 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPattaranutaporn, P | |
| 245 | 0 | 0 |
_aPhase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cJun 2001 |
||
| 300 |
_a404-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 | _aBrachytherapy |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xadverse effects |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aThirapakawong, C | |
| 700 | 1 | _aChansilpa, Y | |
| 700 | 1 | _aTherasakvichya, S | |
| 700 | 1 | _aIeumwananontachai, N | |
| 700 | 1 | _aThephamongkhol, K | |
| 773 | 0 |
_tGynecologic oncology _gvol. 81 _gno. 3 _gp. 404-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/gyno.2001.6197 _zAvailable from publisher's website |
| 999 |
_c11303034 _d11303034 |
||